Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Public ClinicalTrials.gov record NCT01026493. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase I/II Study of ABT-888 in Combination With Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma
Study identification
- NCT ID
- NCT01026493
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Enrollment
- 257 participants
Conditions and interventions
Conditions
Interventions
- temozolomide 60 mg x 21 days Drug
- temozolomide 75 mg x 21 days Drug
- ABT-888 20 mg x 21 days Drug
- ABT-888 40 mg x 21 days Drug
- Temozolomide 150 mg x 5 days Drug
- ABT-888 40 mg x 5 days Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2010
- Primary completion
- Apr 30, 2014
- Completion
- Nov 30, 2016
- Last update posted
- Jul 1, 2017
2010 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rebecca and John Moores UCSD Cancer Center | La Jolla | California | 92093-0658 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Cancer Research Center of Hawaii | Honolulu | Hawaii | 96813 | — |
| Queen's Cancer Institute at Queen's Medical Center | Honolulu | Hawaii | 96813 | — |
| Hawaii Medical Center - East | Honolulu | Hawaii | 96817 | — |
| Leeward Radiation Oncology | ‘Ewa Beach | Hawaii | 96706 | — |
| University of Chicago Cancer Research Center | Chicago | Illinois | 60637-1470 | — |
| CCOP - Kansas City | Prairie Village | Kansas | 66208 | — |
| Central Baptist Hospital | Lexington | Kentucky | 40503-9985 | — |
| Louisville Oncology at Norton Cancer Institute - Louisville | Louisville | Kentucky | 40202 | — |
| Regional Cancer Center at Singing River Hospital | Pascagoula | Mississippi | 39581 | — |
| Renown Institute for Cancer at Renown Regional Medical Center | Reno | Nevada | 89502 | — |
| Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756-0002 | — |
| Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08903 | — |
| Highland Hospital of Rochester | Rochester | New York | 14620 | — |
| James P. Wilmot Cancer Center at University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Legacy Good Samaritan Hospital & Comprehensive Cancer Center | Portland | Oregon | 97210 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01026493, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01026493 live on ClinicalTrials.gov.